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Background: Bernard–Soulier Syndrome (BSS) is a rare congenital bleeding disorder charac-
terized by thrombocytopenia. BSS causes bruising, epistaxis, gingival bleeding hemorrhage,
post-partum bleeding, gastrointestinal bleeding and post-traumatic hemorrhage, but there
is no report of hemoptysis in BSS.
Case report: A 14-year-old girl was referred to this center due to massive hemoptysis. Her
chest X-ray revealed complete collapse of the left lung. Rigid bronchoscopy was performed
and the intrabronchial clots were removed. Smear and culture of direct sputum was
positive for Mycobacterium tuberculosis. She received anti-tuberculosis treatment. During
treatment, she developed massive vaginal bleeding, because of drug interaction between
rifampin and low dose contraceptive (LD), which she had been taking for control of massive
menstrual bleeding. Her vaginal bleeding was controlled by platelet infusion and
recombinant factor 7 infusion. After two months of anti-TB treatment, the sputum smear
and culture examination became negative. One year after treatment, the pulmonary
tuberculosis was completely cured and no hemoptysis occurred.
Conclusion: When hemoptysis occurs in patients with BSS, other differential diagnoses
should also be considered.
 2014 Published by Elsevier Ltd. on behalf of Asian-African Society for Mycobacteriology.Introduction
Bernard–Soulier Syndrome (BSS) is a rare congenital bleeding
disorder characterized by thrombocytopenia with giant
platelets [1,2]. This syndrome is caused by a quantitative or
qualitative defect in the receptor complex of 1b/1X glycopro-
tein-located on the platelet membrane as a main recipient
for Von Willebrand factor (vWF) [3–5]. The clinical manifesta-
tions of this syndrome are: bruising, epistaxis, gingival
bleeding hemorrhage, post-partum bleeding, gastrointestinal
bleeding and post-traumatic hemorrhage [5]. Occurrence ofspontaneous bleeding is unusual in BSS, and there is no
report of hemoptysis in this syndrome [6].
Case report
A 14-year-old girl was referred to this center with massive
hemoptysis which was diagnosed as BSS. She suffered from
cough and hemoptysis for longer than 48-h. The patient’s
main complaint was pain in the left side of her chest, and
she did not present with any other types of pain. Upon
physical check-up, no breath sound was heard in the left
Fig. 3 – CT scan shows the complete collapse of left lung.
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let count was 10,000 per ml3. The other clinical parameters
such as white cells count, hemoglobin, liver function test,
urine test and ECG were normal. The X-ray film and CT scan
of chest showed infiltration and bronchiectasis in the left
lower lobe with cardiac and mediastinal shift being observed
(Figs. 1–3). To remove the clot, rigid bronchoscopy under
general anesthesia was performed. Then, due to patient’s
resistance to platelet infusion, the platelet infusion was
converted to Novoseven infusion. For definitive diagnosis,
more complementary examinations were performed, i.e.,
sputum samples were investigated for the presence of acid-
fast bacilli (AFB). Based on the positivity report of smear
and culture, the patient received Isoniazid (INH), Rifampin
(RF), Pyrazinamid (PZA) and Ethambutol (ETB) for anti-TB
treatment. However, as the level of liver enzymes increased
and hepatotoxicity were observed, the drug regimen was
changed to INH, ETB and Ciprofloxacin (Cip). After taking this
regimen, the liver enzyme levels returned to normal status.
The patient received this regimen for 12 months. After one
year of treatment, the patient was healthy and her monthly
check-up showed no sign of diseases.Fig. 2 – CT scan shows the infiltration and bronchiectasis of
left lower with cardiac and mediastinal shift.
Fig. 1 – Chest-X ray shows the shift of cardiac and
mediastinal to the left; as a result patient had complete
collapsed of left lung.Discussion
BSS, also called hemorrhagiparous thrombocytic dystrophy, is
a rare autosomal recessive coagulopathy (bleeding disorder)
that causes a deficiency of glycoprotein Ib (GpIb), the receptor
for vWF, an important glycoprotein involved in hemostasis
[2,7]. In childhood, BSS presents from moderate to severe
bleeding. The syndrome’s symptoms consist of: bruising, epi-
staxis, gingival bleeding hemorrhage, post-partum bleeding,
gastrointestinal bleeding and post-traumatic hemorrhage;
while spontaneous bleeding is absolutely unusual [6,7]. In this
study, hemoptysis was shown as a clinical manifestation of
BSS. Indeed, hemoptysis is an awareness sign and should be
considered as a symptom of different disease that needs
more detailed investigations. The most common causes of
hemoptysis are: bronchiectasis, pulmonary tuberculosis and
lung cancer. Generally, radiologic manifestations of disease,
history, clinical findings upon physical check up and demo-
graphic factors guide us toward the evaluation of patients
with minor hemoptysis. To the contrary, massive hemoptysis
is a life-threatening process and it may cause hospitalization
in the intensive care unit (ICU) as well. Immediate examina-
tion of the patient by emergency bronchoscopy is necessary
for the localization of the bleeding site. Intrabronchial and
bronchial artery embolization techniques should be consid-
ered as an effective treatment for massive bleeding control
and to reduce the requirement of emergency surgical therapy
[9]. Additionally, in such cases, the protective treatment
which consists of parents or patients’ education play impor-
tant roles; this consists of training individuals how to handle
different types of bleeding, to avoid of minor trauma, to avoid
the use of anti-platelet drugs, to handle iron therapy and to
avoid the use of Halothane as an anesthetic drug due to a dis-
order in the platelet’s normal activity. Last, but not the least,
prescribing Novoseven factor for patients with severe
bleeding. NovoSeven is a recombinant human coagulation
FactorVIIa (rFVIIa), and is a vitamin K-dependent glycoprotein
consisting of 406 amino acid residues (MW 50 KDa) [8,10].
NovoSeven in patients with thrombocytopenia or in
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thrombin on a surface of activated platelets for homeostasis
actions [10].
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